261 related articles for article (PubMed ID: 15212687)
1. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma.
Lewis MJ; Wiebe JP; Heathcote JG
BMC Cancer; 2004 Jun; 4():27. PubMed ID: 15212687
[TBL] [Abstract][Full Text] [Related]
2. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.
Wiebe JP; Lewis MJ
BMC Cancer; 2003 Mar; 3():9. PubMed ID: 12659654
[TBL] [Abstract][Full Text] [Related]
3. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis.
Hevir N; Vouk K; Sinkovec J; Ribič-Pucelj M; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):217-26. PubMed ID: 21232532
[TBL] [Abstract][Full Text] [Related]
4. The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion.
Wiebe JP; Muzia D; Hu J; Szwajcer D; Hill SA; Seachrist JL
Cancer Res; 2000 Feb; 60(4):936-43. PubMed ID: 10706108
[TBL] [Abstract][Full Text] [Related]
5. Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment.
Wiebe JP; Souter L; Zhang G
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):129-40. PubMed ID: 16806904
[TBL] [Abstract][Full Text] [Related]
6. Progesterone metabolites in breast cancer.
Wiebe JP
Endocr Relat Cancer; 2006 Sep; 13(3):717-38. PubMed ID: 16954427
[TBL] [Abstract][Full Text] [Related]
7. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A
Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289
[TBL] [Abstract][Full Text] [Related]
8. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
[TBL] [Abstract][Full Text] [Related]
11. Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines.
Sinreih M; Anko M; Zukunft S; Adamski J; Rižner TL
Chem Biol Interact; 2015 Jun; 234():297-308. PubMed ID: 25463305
[TBL] [Abstract][Full Text] [Related]
12. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
13. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
14. The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics.
Wiebe JP; Lewis MJ; Cialacu V; Pawlak KJ; Zhang G
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):201-8. PubMed ID: 15860263
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, metabolism and levels of the neuroactive steroid, 3alpha-hydroxy-4-pregnen-20-one (3alphaHP), in rat pituitaries.
Wiebe JP; Boushy D; Wolfe M
Brain Res; 1997 Aug; 764(1-2):158-66. PubMed ID: 9295205
[TBL] [Abstract][Full Text] [Related]
16. Membrane 5alpha-pregnane-3,20-dione (5alphaP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5alphaP and down-regulated by the progesterone metabolites, 3alpha-dihydroprogesterone and 20alpha-dihydroprogesterone, with associated changes in cell proliferation and detachment.
Pawlak KJ; Zhang G; Wiebe JP
J Steroid Biochem Mol Biol; 2005 Nov; 97(3):278-88. PubMed ID: 16154741
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone metabolism in the cervix during pregnancy and parturition.
Andersson S; Minjarez D; Yost NP; Word RA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2366-74. PubMed ID: 18364378
[TBL] [Abstract][Full Text] [Related]
18. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM
J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391
[TBL] [Abstract][Full Text] [Related]
19. Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway.
Jin Y; Mesaros AC; Blair IA; Penning TM
Biochem J; 2011 Jul; 437(1):53-61. PubMed ID: 21521174
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-4-pregnen-20-one in MCF-7 breast cancer cells.
Weiler PJ; Wiebe JP
Biochem Biophys Res Commun; 2000 Jun; 272(3):731-7. PubMed ID: 10860824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]